Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Heidelberg Pharma AG Director's Dealing 2026

Mar 10, 2026

201_dirs_2026-03-10_593ecd3e-8f32-483f-8595-5814956d0183.html

Director's Dealing

Open in viewer

Opens in your device viewer

News Details

Directors’ Dealings | 10 March 2026 08:29

Heidelberg Pharma AG: Dr. Birgit Kudlek, sell

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

10.03.2026 / 08:28 CET/CEST

The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title: Dr.
First name: Birgit
Last name(s): Kudlek

2. Reason for the notification

a) Position / status

Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Heidelberg Pharma AG

b) LEI

391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: DE000A11QVV0

b) Nature of the transaction

Disposal

c) Price(s) and volume(s)

Price(s) Volume(s)
3.14 EUR 3,140.00 EUR
3.13 EUR 4,278.71 EUR

d) Aggregated information

Price Aggregated volume
3.1342 EUR 7,418.1100 EUR

e) Date of the transaction

09/03/2026; UTC+1

f) Place of the transaction

Name: LS Exchange
MIC: HAMN

10.03.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.


Language: English
Company: Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com
End of News EQS News Service

103580  10.03.2026 CET/CEST